Severe endothelial injury in a renal transplant patient receiving cyclosporine.

No abstract is available for this paper.

• Publication year

  1990

• Venue

  Transplantation

• Publication date

  1990-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/00007890-199006000-00038PMID 2193445
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Glomerular actions of endothelin in vivo.

  1989cited by this paper
• Cyclosporine toxicity on cultured rat microvascular endothelial cells.

  1989cited by this paper
• Endotoxin stimulates endothelin-release in vivo and in vitro as determined by radioimmunoassay.

  1989cited by this paper
• Plasma endothelin levels in patients with uraemia.

  1989cited by this paper
• A novel potent vasoconstrictor peptide produced by vascular endothelial cells

  1988cited by this paper
• Potent selective vasoconstrictor effects of endothelin in the pig kidney in vivo.

  1988cited by this paper
• Glomerular hemodynamics and hormonal participation on cyclosporine nephrotoxicity.

  1987cited by this paper
• Long-term results of cyclosporine treatment in renal transplantation.

  1986cited by this paper
• Effect of cyclosporine administration on renal hemodynamics in conscious rats.

  1985cited by this paper
• Renal histopathology in kidney transplant recipients immunosuppressed with cyclosporin A: results of an international workshop.

  1985cited by this paper
• Nephrotoxicity of cyclosporin A after allogeneic marrow transplantation: glomerular thromboses and tubular injury.

  1981cited by this paper

• Posterior Reversible Encephalopathy Syndrome: A Review

  2017cites this paper
• Thrombotic complications associated with stem cell transplantation.

  2012cites this paper
• Relaxing Factors in Epicardial andResistance Coronary Arteries

  2011cites this paper
• Reversible posterior leucoencephalopathy syndrome associated with anticancer drugs

  2009cites this paper
• Reversible posterior leukoencephalopathy syndrome in cancer

  2008cites this paper
• Chapter 88 – Diagnosis and Management of Renal Allograft Dysfunction

  2008cites this paper
• Endothelin‐1 plasma levels and hypertension in cyclosporine‐treated renal transplant patients

  2005cites this paper
• Involvement of endothelin and nitric oxide in cyclosporine A-induced contractions in guinea pig isolated gallbladder strips.

  2005cites this paper
• Pathophysiologie und Therapie des reversiblen posterioren Leukoenzephalopathiesyndroms (RPLS)

  2004cites this paper
• Cyclosporine increases endothelin-1 plasma levels in renal transplant recipients.

  2004cites this paper
• Posterior reversibile encephalopathic syndrom: case report and review of literature

  2003cites this paper
• Successful retransplantation using rapamycin in a patient with previous calcineurin inhibitor-induced posterior leukoencephalopathy syndrome.

  2003cites this paper
• [Posterior reversible encephalopathy syndrome].

  2003cites this paper
• Reversible posterior leucoencephalopathy syndrome associated with bone marrow transplantation.

  2001cites this paper
• Endothelins: vasoactive modulators of renal function in health and disease.

  2001cites this paper
• Hemolytic Uremic Syndrome Associated with Influenza A Virus Infection in an Adult Renal Allograft Recipient: Case Report and Review of the Literature

  2000cites this paper
• Endothelin-1 and endothelin receptor status in kidney transplants undergoing acute rejection.

  1999cites this paper
• Pulmonary capillaritis: a possible histologic form of acute pulmonary allograft rejection.

  1998cites this paper
• Thrombo-Embolic Stroke, Moya-Moya Phenomenon and Primary Oxalosis

  1998cites this paper
• Experimental and clinical study of endothelin-1 in renal failure

  1998cites this paper
• Red blood cell rigidification during cyclosporin therapy: a possible early warning signal for adverse reactions.

  1998cites this paper
• Interactions of cyclosporin A and amlodipine: blood cyclosporin A levels, hypertension and kidney function.

  1998cites this paper
• Prognostic factors and early resumption of cyclosporin A in renal allograft recipients with thrombotic microangiopathy and hemolytic uremic syndrome

  1997cites this paper
• Role of endothelin receptor subtypes in the systemic and renal responses to endothelin-1 in humans.

  1997cites this paper
• Endothelin-1-induced vasopressor responses in essential hypertension.

  1997cites this paper
• Endothelin in organ transplantation.

  1996cites this paper
• Selective downregulation of ETA receptor mRNA in renal transplant recipients on cyclosporin A revealed by quantitative RT-PCR

  1996cites this paper
• Selective downregulation of ETA receptor mRNA in renal transplant recipients on cyclosporin A revealed by quantitative RT-PCR.

  1996cites this paper
• A reversible posterior leukoencephalopathy syndrome.

  1996cites this paper
• The endothelin system in the kidney

  1996cites this paper
• Endothelin and Renal Function: From Theory to Therapy

  1995cites this paper
• Smoke inhalation causes a delayed increase in airway blood flow to primarily uninjured lung areas

  1995cites this paper
• Interactions of nifedipine with the renovascular effects of endothelin in humans.

  1995cites this paper
• Endothelin plasma levels in acute graft rejection after heart transplantation.

  1995cites this paper
• Effectiveness of enalapril versus nifedipine to antagonize blood pressure and the renal response to endothelin in humans.

  1995cites this paper
• Urinary endothelin in glomerulonephritis patients with normal renal function.

  1994cites this paper
• Pattern of endothelin immunostaining during rejection episodes after kidney transplantation.

  1994cites this paper
• Lipid abnormalities in red blood cell and plasma phospholipids in cyclosporine-treated heart transplant recipients.

  1994cites this paper
• Cyclosporine Impairs Release of Endothelium‐Derived Relaxing Factors in Epicardial and Resistance Coronary Arteries

  1994cites this paper
• Plasma endothelin level following kidney transplantation.

  1994cites this paper
• [Changes of plasma endothelin level in the early post-renal transplantation period].

  1994cites this paper
• Cardiovascular effects of cyclosporine A and OG 37-325 after chronic administration to conscious rats: role of endothelin.

  1994cites this paper
• Pathophysiologic role of endothelin-1 in renal function in rats with endotoxin shock.

  1994cites this paper
• Cyclosporine or rejection enhance secretion of von Willebrand factor in renal transplantation.

  1994cites this paper
• Renal allograft infarction is a cause of early kidney transplant loss in the cyclosporine A era.

  1994cites this paper
• Effects of endothelin-1 on renal function in humans: implications for physiology and pathophysiology.

  1994cites this paper
• Erythrocyte deformability, endothelin levels, and renal function in cyclosporin-treated renal transplant recipients: effects of intervention with fish oil and corn oil.

  1993cites this paper
• Cyclosporine-associated thrombotic microangiopathy: report of two cases with good outcome and successful subsequent reuse.

  1993cites this paper
• CYCLOSPORINE‐INDUCED ELEVATION IN CIRCULATING ENDOTHELIN‐1 IN PATIENTS WITH SOLID‐ORGAN TRANSPLANTS

  1993cites this paper
• Potential Role of Endothelin in the Physiological and Pathological Regulation of Kidney Function

  1993cites this paper
• Effects of In Vivo Cyclosporine Administration on Endothelium‐Dependent Responses in Isolated Vascular Rings

  1992cites this paper
• Diminished acetylcholine-induced vasodilation in renal microvessels of cyclosporine-treated rats.

  1992cites this paper
• Cyclosporine A toxicity is associated with reduced endothelin immunoreactivity in renal endothelium.

  1992cites this paper
• Endothelin receptor antagonism is protective in in vivo acute cyclosporine toxicity.

  1992cites this paper
• Scieroderma and the kidney

  1992cites this paper
• Chronic cyclosporine therapy impairs endothelium-dependent relaxation in the renal artery of the rat.

  1992cites this paper
• Scleroderma and the kidney.

  1992cites this paper
• Daily renal hypoperfusion induced by cyclosporine in patients with renal transplantation.

  1992cites this paper
• Cyclosporine, Hypertension, and the Kidney

  1992cites this paper
• Reversible cyclosporine arteriolopathy.

  1992cites this paper
• Altered Renovascular Endothelial Functions During Nephrotoxicity

  1991cites this paper
• The role of vascular endothelial cells in transplantation.

  1991cites this paper
• Biological actions and pathophysiologic significance of endothelin in the kidney.

  1991cites this paper
• Thrombotic microangiopathies.

  1991cites this paper
• EVIDENCE THAT LIPOSOME INCORPORATION OF CYCLOSPORINE REDUCES ITS TOXICITY AND POTENTIATES ITS ABILITY TO PROLONG SURVIVAL OF CARDIAC ALLOGRAFTS IN MICE

  1991cites this paper
• INCREASED URINARY EXCRETION OF ENDOTHELIN‐1 AND ITS PRECURSOR, BIG‐ENDOTHELIN-1, IN RATS CHRONICALLY TREATED WITH CYCLOSPORINE

  1991cites this paper
• Nephroloqy Dialysis Transplantation Selective downregulation of ETA receptor mRNA in renal transplant recipients on cyclosporin A revealed by quantitative RT-PCR

  year unknowncites this paper